Anonymous ID: 7a1b9c Aug. 13, 2018, 7:12 a.m. No.2582008   🗄️.is 🔗kun

>>2581896

POTUS says, "...because Amarosa says GREAT things about me...

 

G.R.E.A.T.

Gang Resistance Education And Training, abbreviated G.R.E.A.T., provides a school-based, police officer instructed program that includes classroom instruction and various learning activities, the use of law enforcement officers having several advantages. They have a wide range of experience in recognizing and combatting criminal behaviour, they have the ability to recognize gang members, they are equipped with a referral knowledge, and most importantly can be a positive role model to students.

 

The instruction of life skills is the foundation of the program. In accordance with a study by Dr. Esbensen in 2000, delinquency often serves as a precursor to gang involvement, the GREAT program the focuses on providing life skills to students to help them avoid delinquent behavior and resorting to violence to solve problems. Communities need not have a gang problem in order to benefit from the program as its primary objective is prevention and is intended as an immunization against delinquency, youth violence, and gang membership.

 

The program was originally administered by the Bureau of Alcohol, Tobacco and Firearms of the US Department of the Treasury, however, when the ATF was transferred to the United States Department of Justice, it became administered by the Office of Justice Programs of the Bureau of Justice Assistance.

 

Contents

1 History

2 The Goal

3 The Curriculum

4 Officer Selection

5 Recent program evaluation

5.1 Results

6 See also

7 References

8 External links

 

Read moar: https://en.wikipedia.org/wiki/Gang_Resistance_Education_and_Training

Anonymous ID: 7a1b9c Aug. 13, 2018, 7:16 a.m. No.2582033   🗄️.is 🔗kun   >>2035 >>2273

>>2582010

 

New cancer drug shown to be extremely effective in Phase I trials on patients with solid tumors or brain tumors and produced no significant side effects. Developed by a Cincinnati biotech firm, the biologic-type drug is being trialed at four sites across the country; NoName is on this drug through a trial at the University of New Mexico. BXQ-350 kills over 60 different types of human cancer cells in test tubes and "is toxic to cancer cells, only. The nanovesicals bypass the blood brain barrier. BXQ-350 has an entirely new and novel mechanism of action. "

R&D biotech company website: https://www.bexionpharma.com

 

Bexion social media:

https://twitter.com/BexionPharma

https://www.facebook.com/Bexion

 

Manufacturer of active ingredient: https://www.ptcommunity.com/wire/cytovance-biologics-inc-announces-bexion-pharmaceuticals-inc-has-chosen-cytovance-manufacture

————————-